MedPath

CHANTIX

These highlights do not include all the information needed to use CHANTIX safely and effectively. See full prescribing information for CHANTIX. CHANTIX (varenicline) tablets, for oral useInitial U.S. Approval: 2006

Approved
Approval ID

b4403cea-6300-4d89-8fde-5149a80b08b9

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 18, 2017

Manufacturers
FDA

Aphena Pharma Solutions - Tennessee, LLC

DUNS: 128385585

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

varenicline tartrate

PRODUCT DETAILS

NDC Product Code43353-899
Application NumberNDA021928
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateDecember 18, 2017
Generic Namevarenicline tartrate

INGREDIENTS (10)

VARENICLINE TARTRATEActive
Quantity: 1 mg in 1 1
Code: 82269ASB48
Classification: ACTIM
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92J
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSE, UNSPECIFIEDInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CHANTIX - FDA Drug Approval Details